Diabetes drug found no better than placebo at treating nonalcoholic fatty liver disease

Posted by on May 12, 2016 8:06 pm
Categories: health

A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed under the name Januvia.

Leave a Reply

Your email address will not be published. Required fields are marked *